Bicycle Therapeutics plcBCYCNASDAQ
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank81
5Y CAGR-4.1%
Year-over-Year Change
Year-over-year gross profit growth rate
5Y CAGR
-4.1%/yr
Long-term compound
Percentile
P81
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 117.23% |
| Q2 2025 | -44.01% |
| Q1 2025 | 9.68% |
| Q4 2024 | -21.86% |
| Q3 2024 | -559.05% |
| Q2 2024 | -52.07% |
| Q1 2024 | 266.35% |
| Q4 2023 | -0.39% |
| Q3 2023 | -53.04% |
| Q2 2023 | 132.78% |
| Q1 2023 | 53.72% |
| Q4 2022 | 4.77% |
| Q3 2022 | -30.56% |
| Q2 2022 | 13.42% |
| Q1 2022 | 2.36% |
| Q4 2021 | -12.97% |
| Q3 2021 | 142.75% |
| Q2 2021 | -1.27% |
| Q1 2021 | 129.11% |
| Q4 2020 | -261.63% |
| Q3 2020 | 144.56% |
| Q2 2020 | 123.64% |
| Q1 2020 | -385.75% |
| Q4 2019 | 74.96% |
| Q3 2019 | -8.95% |
| Q2 2019 | -4743.52% |
| Q1 2019 | 101.99% |
| Q4 2018 | -34.82% |
| Q3 2018 | -23.83% |
| Q2 2018 | -261.38% |
| Q1 2018 | 73.88% |
| Q4 2017 | 0.00% |